Corteva (NYSE:CTVA) Insider Sells $636,207.05 in Stock

Corteva, Inc. (NYSE:CTVA) insider Brian Titus sold 8,311 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Corteva Stock Up 1.9%

Corteva stock traded up $1.44 during mid-day trading on Tuesday, reaching $77.90. 3,064,159 shares of the company’s stock were exchanged, compared to its average volume of 4,069,610. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $77.98. The company has a fifty day moving average of $70.93 and a 200-day moving average of $68.60. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The company has a market cap of $52.39 billion, a P/E ratio of 49.31, a P/E/G ratio of 2.60 and a beta of 0.75.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the prior year, the business earned $0.32 EPS. Corteva’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio is presently 45.57%.

Institutional Investors Weigh In On Corteva

A number of hedge funds have recently made changes to their positions in CTVA. MV Capital Management Inc. bought a new position in shares of Corteva during the 4th quarter valued at about $43,000. Cambient Family Office LLC acquired a new stake in Corteva during the 4th quarter valued at $366,000. Invesco Ltd. lifted its stake in Corteva by 16.7% in the 4th quarter. Invesco Ltd. now owns 11,404,960 shares of the company’s stock worth $764,474,000 after acquiring an additional 1,630,712 shares in the last quarter. Axxcess Wealth Management LLC lifted its position in shares of Corteva by 1.2% in the fourth quarter. Axxcess Wealth Management LLC now owns 31,120 shares of the company’s stock worth $2,086,000 after purchasing an additional 355 shares in the last quarter. Finally, Corient Private Wealth LLC boosted its stake in shares of Corteva by 4.8% during the 4th quarter. Corient Private Wealth LLC now owns 203,950 shares of the company’s stock valued at $13,422,000 after buying an additional 9,388 shares during the period. Institutional investors own 81.54% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CTVA. UBS Group downgraded Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. Deutsche Bank Aktiengesellschaft upped their target price on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Mizuho raised their price target on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 17th. Citigroup upped their target price on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Finally, CICC Research lifted their price target on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Wednesday, February 11th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, Corteva presently has an average rating of “Moderate Buy” and a consensus target price of $82.30.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.